معرفی
Thomas G. Adams, PhD, is a NIH-funded postdoctoral fellow at the Yale School of Medicine’s OCD Research Clinic, within the Department of Psychiatry. He holds a PhD in clinical psychology from the University of Arkansas and completed a pre-doctoral internship at the Charleston Consortium. His research focuses on improving treatments for OCD and related psychopathology through cognitive-behavioral and neurobiological mechanisms, including transcranial stimulation techniques like TMS and tDCS.
Education:
- PhD in Clinical Psychology, University of Arkansas (2014)
- Pre-doctoral Internship, Charleston Consortium (Medical University of South Carolina/Ralph H. Johnson VA Medical Center)
Research Interests: Dr. Adams investigates mechanisms underlying CBT efficacy for OCD, integrates somatic interventions (e.g., TMS) with behavioral therapies, and explores how disgust interacts with attentional processes in OCD maintenance. His work bridges clinical psychology, neuroscience, and translational medicine.
Recent Research Trends: Recent publications span OCD comorbidity assessment, trauma-related mental health (e.g., veterans with TBI), and exercise’s role in fear extinction learning. He collaborates on studies involving neurobiological mechanisms and smoking cessation in HIV-positive populations.
Grants & Clinical Trials: Sub-Investigator in a NIH-funded study (HIC ID 0803003626) on OCD biomarkers and treatment response. Active in clinical trials targeting OCD, PTSD, and addiction.
Labs/Teams: OCD Research Clinic at Yale School of Medicine, collaborating with Robert Pietrzak, Kelli Crombie, and others on interdisciplinary projects.
